Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of pemetrexed disodium in previously treated metastatic urothelial carcinoma was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Urothelial Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-05-20